Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:35 PM
Study NCT ID:
NCT05552651
Status:
UNKNOWN
Last Update Posted:
2022-09-23
First Post:
2022-09-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Sponsor:
Tao Jiang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-20
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-14
First Submit QC Date:
None
Study First Post Date:
2022-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-21
Last Update Post Date:
2022-09-23
Last Update Post Date Type:
ACTUAL